These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. TLR2 Promotes Vascular Smooth Muscle Cell Chondrogenic Differentiation and Consequent Calcification via the Concerted Actions of Osteoprotegerin Suppression and IL-6-Mediated RANKL Induction. Lee GL; Yeh CC; Wu JY; Lin HC; Wang YF; Kuo YY; Hsieh YT; Hsu YJ; Kuo CC Arterioscler Thromb Vasc Biol; 2019 Mar; 39(3):432-445. PubMed ID: 30626205 [TBL] [Abstract][Full Text] [Related]
4. The function and meaning of receptor activator of NF-κB ligand in arterial calcification. Nie B; Zhou SQ; Fang X; Zhang SY; Guan SM J Huazhong Univ Sci Technolog Med Sci; 2015 Oct; 35(5):666-671. PubMed ID: 26489619 [TBL] [Abstract][Full Text] [Related]
5. Induction of osteoclast differentiation by Runx2 through receptor activator of nuclear factor-kappa B ligand (RANKL) and osteoprotegerin regulation and partial rescue of osteoclastogenesis in Runx2-/- mice by RANKL transgene. Enomoto H; Shiojiri S; Hoshi K; Furuichi T; Fukuyama R; Yoshida CA; Kanatani N; Nakamura R; Mizuno A; Zanma A; Yano K; Yasuda H; Higashio K; Takada K; Komori T J Biol Chem; 2003 Jun; 278(26):23971-7. PubMed ID: 12697767 [TBL] [Abstract][Full Text] [Related]
6. Hyperhomocysteinemia induces vascular calcification by activating the transcription factor RUNX2 via Krüppel-like factor 4 up-regulation in mice. Zhu L; Zhang N; Yan R; Yang W; Cong G; Yan N; Ma W; Hou J; Yang L; Jia S J Biol Chem; 2019 Dec; 294(51):19465-19474. PubMed ID: 31628194 [TBL] [Abstract][Full Text] [Related]
7. A novel role of FKN/CX3CR1 in promoting osteogenic transformation of VSMCs and atherosclerotic calcification. Yang T; Guo L; Chen L; Li J; Li Q; Pi Y; Zhu J; Zhang L Cell Calcium; 2020 Nov; 91():102265. PubMed ID: 32814243 [TBL] [Abstract][Full Text] [Related]
8. Oxidative stress induces vascular calcification through modulation of the osteogenic transcription factor Runx2 by AKT signaling. Byon CH; Javed A; Dai Q; Kappes JC; Clemens TL; Darley-Usmar VM; McDonald JM; Chen Y J Biol Chem; 2008 May; 283(22):15319-27. PubMed ID: 18378684 [TBL] [Abstract][Full Text] [Related]
10. Involvement of upstream stimulatory factors 1 and 2 in RANKL-induced transcription of tartrate-resistant acid phosphatase gene during osteoclast differentiation. Liu Y; Shi Z; Silveira A; Liu J; Sawadogo M; Yang H; Feng X J Biol Chem; 2003 Jun; 278(23):20603-11. PubMed ID: 12663664 [TBL] [Abstract][Full Text] [Related]
11. PKA-induced receptor activator of NF-kappaB ligand (RANKL) expression in vascular cells mediates osteoclastogenesis but not matrix calcification. Tseng W; Graham LS; Geng Y; Reddy A; Lu J; Effros RB; Demer L; Tintut Y J Biol Chem; 2010 Sep; 285(39):29925-31. PubMed ID: 20663885 [TBL] [Abstract][Full Text] [Related]
12. Ferryl Hemoglobin Inhibits Osteoclastic Differentiation of Macrophages in Hemorrhaged Atherosclerotic Plaques. Zavaczki E; Gáll T; Zarjou A; Hendrik Z; Potor L; Tóth CZ; Méhes G; Gyetvai Á; Agarwal A; Balla G; Balla J Oxid Med Cell Longev; 2020; 2020():3721383. PubMed ID: 32184915 [TBL] [Abstract][Full Text] [Related]
13. Inhibition of FOXO1/3 promotes vascular calcification. Deng L; Huang L; Sun Y; Heath JM; Wu H; Chen Y Arterioscler Thromb Vasc Biol; 2015 Jan; 35(1):175-83. PubMed ID: 25378413 [TBL] [Abstract][Full Text] [Related]
15. AKT-independent activation of p38 MAP kinase promotes vascular calcification. Yang Y; Sun Y; Chen J; Bradley WE; Dell'Italia LJ; Wu H; Chen Y Redox Biol; 2018 Jun; 16():97-103. PubMed ID: 29495001 [TBL] [Abstract][Full Text] [Related]
16. Receptor activator of nuclear factor-kappaB ligand-induced nuclear factor of activated T cells (C1) autoregulates its own expression in osteoclasts and mediates the up-regulation of tartrate-resistant acid phosphatase. Fretz JA; Shevde NK; Singh S; Darnay BG; Pike JW Mol Endocrinol; 2008 Mar; 22(3):737-50. PubMed ID: 18063694 [TBL] [Abstract][Full Text] [Related]
17. Aging increases stromal/osteoblastic cell-induced osteoclastogenesis and alters the osteoclast precursor pool in the mouse. Cao JJ; Wronski TJ; Iwaniec U; Phleger L; Kurimoto P; Boudignon B; Halloran BP J Bone Miner Res; 2005 Sep; 20(9):1659-68. PubMed ID: 16059637 [TBL] [Abstract][Full Text] [Related]
18. YY1 is involved in RANKL-induced transcription of the tartrate-resistant acid phosphatase gene in osteoclast differentiation. Shi Z; Silveira A; Patel P; Feng X Gene; 2004 Dec; 343(1):117-26. PubMed ID: 15563837 [TBL] [Abstract][Full Text] [Related]
19. Runx-2 is not essential for the vitamin D-regulated expression of RANKL and osteoprotegerin in osteoblastic cells. Notoya M; Otsuka E; Yamaguchi A; Hagiwara H Biochem Biophys Res Commun; 2004 Nov; 324(2):655-60. PubMed ID: 15474477 [TBL] [Abstract][Full Text] [Related]
20. Complex regulation of tartrate-resistant acid phosphatase (TRAP) expression by interleukin 4 (IL-4): IL-4 indirectly suppresses receptor activator of NF-kappaB ligand (RANKL)-mediated TRAP expression but modestly induces its expression directly. Yu M; Moreno JL; Stains JP; Keegan AD J Biol Chem; 2009 Nov; 284(47):32968-79. PubMed ID: 19801646 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]